Copyright Reports & Markets. All rights reserved.

Global Preclinical Toxicology Service Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Preclinical Toxicology Service by Type
    • 1.3.1 Overview: Global Preclinical Toxicology Service Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Preclinical Toxicology Service Consumption Value Market Share by Type in 2025
    • 1.3.3 Genetic Toxicity Testing
    • 1.3.4 Reproductive Toxicity Testing
    • 1.3.5 Immunotoxicity Testing
    • 1.3.6 Others
  • 1.4 Global Preclinical Toxicology Service Market by Application
    • 1.4.1 Overview: Global Preclinical Toxicology Service Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Biopharmaceutical Company
    • 1.4.3 Research Laboratory
    • 1.4.4 Others
  • 1.5 Global Preclinical Toxicology Service Market Size & Forecast
  • 1.6 Global Preclinical Toxicology Service Market Size and Forecast by Region
    • 1.6.1 Global Preclinical Toxicology Service Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Preclinical Toxicology Service Market Size by Region, (2021-2032)
    • 1.6.3 North America Preclinical Toxicology Service Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Preclinical Toxicology Service Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Preclinical Toxicology Service Market Size and Prospect (2021-2032)
    • 1.6.6 South America Preclinical Toxicology Service Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Preclinical Toxicology Service Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Charles River Laboratories
    • 2.1.1 Charles River Laboratories Details
    • 2.1.2 Charles River Laboratories Major Business
    • 2.1.3 Charles River Laboratories Preclinical Toxicology Service Product and Solutions
    • 2.1.4 Charles River Laboratories Preclinical Toxicology Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Charles River Laboratories Recent Developments and Future Plans
  • 2.2 Labcorp
    • 2.2.1 Labcorp Details
    • 2.2.2 Labcorp Major Business
    • 2.2.3 Labcorp Preclinical Toxicology Service Product and Solutions
    • 2.2.4 Labcorp Preclinical Toxicology Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Labcorp Recent Developments and Future Plans
  • 2.3 Eurofins Scientific
    • 2.3.1 Eurofins Scientific Details
    • 2.3.2 Eurofins Scientific Major Business
    • 2.3.3 Eurofins Scientific Preclinical Toxicology Service Product and Solutions
    • 2.3.4 Eurofins Scientific Preclinical Toxicology Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Eurofins Scientific Recent Developments and Future Plans
  • 2.4 PRA Health Sciences
    • 2.4.1 PRA Health Sciences Details
    • 2.4.2 PRA Health Sciences Major Business
    • 2.4.3 PRA Health Sciences Preclinical Toxicology Service Product and Solutions
    • 2.4.4 PRA Health Sciences Preclinical Toxicology Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 PRA Health Sciences Recent Developments and Future Plans
  • 2.5 Envigo
    • 2.5.1 Envigo Details
    • 2.5.2 Envigo Major Business
    • 2.5.3 Envigo Preclinical Toxicology Service Product and Solutions
    • 2.5.4 Envigo Preclinical Toxicology Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Envigo Recent Developments and Future Plans
  • 2.6 WuXi AppTec
    • 2.6.1 WuXi AppTec Details
    • 2.6.2 WuXi AppTec Major Business
    • 2.6.3 WuXi AppTec Preclinical Toxicology Service Product and Solutions
    • 2.6.4 WuXi AppTec Preclinical Toxicology Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 WuXi AppTec Recent Developments and Future Plans
  • 2.7 ICON
    • 2.7.1 ICON Details
    • 2.7.2 ICON Major Business
    • 2.7.3 ICON Preclinical Toxicology Service Product and Solutions
    • 2.7.4 ICON Preclinical Toxicology Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 ICON Recent Developments and Future Plans
  • 2.8 Syneos Health
    • 2.8.1 Syneos Health Details
    • 2.8.2 Syneos Health Major Business
    • 2.8.3 Syneos Health Preclinical Toxicology Service Product and Solutions
    • 2.8.4 Syneos Health Preclinical Toxicology Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Syneos Health Recent Developments and Future Plans
  • 2.9 Biosciences Laboratories
    • 2.9.1 Biosciences Laboratories Details
    • 2.9.2 Biosciences Laboratories Major Business
    • 2.9.3 Biosciences Laboratories Preclinical Toxicology Service Product and Solutions
    • 2.9.4 Biosciences Laboratories Preclinical Toxicology Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Biosciences Laboratories Recent Developments and Future Plans
  • 2.10 Toxikon
    • 2.10.1 Toxikon Details
    • 2.10.2 Toxikon Major Business
    • 2.10.3 Toxikon Preclinical Toxicology Service Product and Solutions
    • 2.10.4 Toxikon Preclinical Toxicology Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Toxikon Recent Developments and Future Plans
  • 2.11 Intertek
    • 2.11.1 Intertek Details
    • 2.11.2 Intertek Major Business
    • 2.11.3 Intertek Preclinical Toxicology Service Product and Solutions
    • 2.11.4 Intertek Preclinical Toxicology Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Intertek Recent Developments and Future Plans
  • 2.12 Scantox
    • 2.12.1 Scantox Details
    • 2.12.2 Scantox Major Business
    • 2.12.3 Scantox Preclinical Toxicology Service Product and Solutions
    • 2.12.4 Scantox Preclinical Toxicology Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Scantox Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Preclinical Toxicology Service Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Preclinical Toxicology Service by Company Revenue
    • 3.2.2 Top 3 Preclinical Toxicology Service Players Market Share in 2025
    • 3.2.3 Top 6 Preclinical Toxicology Service Players Market Share in 2025
  • 3.3 Preclinical Toxicology Service Market: Overall Company Footprint Analysis
    • 3.3.1 Preclinical Toxicology Service Market: Region Footprint
    • 3.3.2 Preclinical Toxicology Service Market: Company Product Type Footprint
    • 3.3.3 Preclinical Toxicology Service Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Preclinical Toxicology Service Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Preclinical Toxicology Service Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Preclinical Toxicology Service Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Preclinical Toxicology Service Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Preclinical Toxicology Service Consumption Value by Type (2021-2032)
  • 6.2 North America Preclinical Toxicology Service Market Size by Application (2021-2032)
  • 6.3 North America Preclinical Toxicology Service Market Size by Country
    • 6.3.1 North America Preclinical Toxicology Service Consumption Value by Country (2021-2032)
    • 6.3.2 United States Preclinical Toxicology Service Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Preclinical Toxicology Service Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Preclinical Toxicology Service Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Preclinical Toxicology Service Consumption Value by Type (2021-2032)
  • 7.2 Europe Preclinical Toxicology Service Consumption Value by Application (2021-2032)
  • 7.3 Europe Preclinical Toxicology Service Market Size by Country
    • 7.3.1 Europe Preclinical Toxicology Service Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Preclinical Toxicology Service Market Size and Forecast (2021-2032)
    • 7.3.3 France Preclinical Toxicology Service Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Preclinical Toxicology Service Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Preclinical Toxicology Service Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Preclinical Toxicology Service Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Preclinical Toxicology Service Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Preclinical Toxicology Service Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Preclinical Toxicology Service Market Size by Region
    • 8.3.1 Asia-Pacific Preclinical Toxicology Service Consumption Value by Region (2021-2032)
    • 8.3.2 China Preclinical Toxicology Service Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Preclinical Toxicology Service Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Preclinical Toxicology Service Market Size and Forecast (2021-2032)
    • 8.3.5 India Preclinical Toxicology Service Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Preclinical Toxicology Service Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Preclinical Toxicology Service Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Preclinical Toxicology Service Consumption Value by Type (2021-2032)
  • 9.2 South America Preclinical Toxicology Service Consumption Value by Application (2021-2032)
  • 9.3 South America Preclinical Toxicology Service Market Size by Country
    • 9.3.1 South America Preclinical Toxicology Service Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Preclinical Toxicology Service Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Preclinical Toxicology Service Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Preclinical Toxicology Service Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Preclinical Toxicology Service Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Preclinical Toxicology Service Market Size by Country
    • 10.3.1 Middle East & Africa Preclinical Toxicology Service Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Preclinical Toxicology Service Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Preclinical Toxicology Service Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Preclinical Toxicology Service Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Preclinical Toxicology Service Market Drivers
  • 11.2 Preclinical Toxicology Service Market Restraints
  • 11.3 Preclinical Toxicology Service Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Preclinical Toxicology Service Industry Chain
  • 12.2 Preclinical Toxicology Service Upstream Analysis
  • 12.3 Preclinical Toxicology Service Midstream Analysis
  • 12.4 Preclinical Toxicology Service Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Preclinical Toxicology Service market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    Preclinical Toxicology Service is one of the key steps in drug development to evaluate the safety, toxicity and potential adverse reactions of candidate drugs or treatment options. These services are usually performed before the drug enters clinical trials and cover acute, subchronic and chronic toxicity studies, as well as genotoxicity, carcinogenicity and reproductive toxicity assessments. The results of preclinical toxicology studies can help pharmaceutical companies and research institutions understand the safety characteristics of candidate drugs and decide whether to advance clinical trials.
    This report is a detailed and comprehensive analysis for global Preclinical Toxicology Service market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Preclinical Toxicology Service market size and forecasts, in consumption value ($ Million), 2021-2032
    Global Preclinical Toxicology Service market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
    Global Preclinical Toxicology Service market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
    Global Preclinical Toxicology Service market shares of main players, in revenue ($ Million), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Preclinical Toxicology Service
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Preclinical Toxicology Service market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Charles River Laboratories, Labcorp, Eurofins Scientific, PRA Health Sciences, Envigo, WuXi AppTec, ICON, Syneos Health, Biosciences Laboratories, Toxikon, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Preclinical Toxicology Service market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Genetic Toxicity Testing
    Reproductive Toxicity Testing
    Immunotoxicity Testing
    Others
    Market segment by Application
    Biopharmaceutical Company
    Research Laboratory
    Others
    Market segment by players, this report covers
    Charles River Laboratories
    Labcorp
    Eurofins Scientific
    PRA Health Sciences
    Envigo
    WuXi AppTec
    ICON
    Syneos Health
    Biosciences Laboratories
    Toxikon
    Intertek
    Scantox
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Preclinical Toxicology Service product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Preclinical Toxicology Service, with revenue, gross margin, and global market share of Preclinical Toxicology Service from 2021 to 2026.
    Chapter 3, the Preclinical Toxicology Service competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Preclinical Toxicology Service market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Preclinical Toxicology Service.
    Chapter 13, to describe Preclinical Toxicology Service research findings and conclusion.

    Buy now